Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Clinical Evaluations & Investigations

The EU MDR and your clinical strategies: All you need to know...

2018 Highlights Include:

Your one stop shop for the latest clinical evaluations and investigations updates
  • New clinical considerations under the MDR: Competent Authority, Notified Body and industry updates
  • Best practice for applying the new MEDDEV 2.7.1 rev 4 guidance
  • Are your Post Market Clinical Follow-Up activities up to scratch?
  • Explore clinical evidence requirements for class III devices in the MDR
  • How do EUDAMED developments impact clinical evaluations and investigations?

Competent Authority and Notified Body perspectives from:
  • Health Products Regulatory Authority
  • TÜV SÜD Product Service GmbH
  • UL International (UK) Ltd.
  • TÜV Rheinland LGA Products GmbH
You’ve got questions. We’ve got the answers.

We’ll be hosting interactive panel discussions on:

  • Sharing experiences with writing a CER following MEDDEV 2.7.1 rev 4
  • Open floor Q&A session – save up your questions from the day to ask our panel
  • A chance to catch up with Competent Authority, Notified Body and industry experts

Free On-Demand Content

Webinars. Webinars. Webinars.

EU MDR Labeling Compliance: Learn the Lessons from UDI

Mark Cusworth, VP Research and Development, PRISYM ID
Andrew Love, VP Capability Development, Be4ward

Latest status and practical experience of implementing the new EU MDR

Bassil Akra, Vice President, Global Focus Teams (Cardiovascular, Orthopeadic and Clinical), TÜV SÜD Product Service GmbH, Germany